Physician profile
Steven Jack Mann
NPI 1154778256
$1,377.06
in general payments reported to CMS, 2019-2025
14 companies · $95.37 in 2025
The $95.37 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $651 · 2022: $330 · 2023: $68.29 · 2024: $233 · 2025: $95.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $396.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $396.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $531.84 | 2021-2024 | Anteralign Spinal System With Titan Nanolock Surface Technology |
| Biohaven Pharmaceuticals, INC. | $275.00 | 2021 | |
| Sanofi-Aventis U.S. LLC | $137.56 | 2021-2023 | |
| Abbvie INC. | $89.70 | 2021-2022 | |
| Painteq LLC | $81.22 | 2024 | Painteq |
| Saluda Medical Americas, INC. | $59.06 | 2024-2025 | Evoke |
| Boston Scientific Corporation | $46.53 | 2021-2023 | |
| Biotronik Nro, INC. | $43.45 | 2025 | Prospera |
| Biohaven Pharmaceutical Holding Company LTD. | $23.58 | 2022 | |
| Scilex Pharmaceuticals INC. | $21.62 | 2021 | |
| Allergan, INC. | $19.27 | 2022 | |
| Horizon Therapeutics Plc | $19.23 | 2022 | |
| Ibsa Pharma INC. | $14.88 | 2021 | |
| Depuy Synthes Sales INC. | $14.12 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Mann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.